Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 1;58(1):2100956.
doi: 10.1183/13993003.00956-2021. Print 2021 Jul.

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase

David M Smadja  1   2   3 , Qun-Ying Yue  4 , Richard Chocron  5 , Olivier Sanchez  6   3   7 , Agnes Lillo-Le Louet  6   8
Affiliations

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase

David M Smadja et al. Eur Respir J. .

Abstract

This study observed an imbalance between venous and arterial thrombotic events in mRNA vaccines while with AZ1222 they are evenly shared. Our analysis highlights cerebral vein thrombosis with the three vaccines. https://bit.ly/3mZqguE

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Q-Y. Yue has nothing to disclose. Conflict of interest: R. Chocron reports personal fees from Aspen, outside the submitted work. Conflict of interest: O. Sanchez reports grants from Bayer, Daichi Sankyo and Portola Pharmaceuticals, personal fees from Actelion, GlaxoSmithKline, Boehringer Ingelheim and Chiesi, non-financial support from Leo Pharma, outside the submitted work. Conflict of interest: A. Lillo-Le Louet has nothing to disclose. Conflict of interest: D.M. Smadja reports personal fees from Carmat, Bayer, BMS, Aspen and Leo Pharma, non-financial support from Boehringer Ingelheim, outside the submitted work.

Comment in

References

    1. Philippe A, Chocron R, Gendron N, et al. . Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis 2021; in press [10.1007/s10456-020-09762-6]. - DOI - PMC - PubMed
    1. Jevnikar M, Sanchez O, Chocron R, et al. . Prevalence of pulmonary embolism in patients with COVID 19 at the time of hospital admission. Eur Respir J 2021; 58: 2100116. - PMC - PubMed
    1. Huertas A, Montani D, Savale L, et al. . Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 2020; 56: 2001634. doi:10.1183/13993003.01634-2020 - DOI - PMC - PubMed
    1. Chocron R, Galand V, Cellier J, et al. . Anticoagulation prior to hospitalization is a potential protective factor for COVID-19: insight from a French multicenter cohort study. J Am Heart Assoc 2021; 10: e018624. - PMC - PubMed
    1. Bate A, Lindquist M, Edwards IR, et al. . A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998; 54: 315–321. doi:10.1007/s002280050466 - DOI - PubMed

LinkOut - more resources